Sodium Bicarbonate
Active ingredient · 2 therapeutic classes
Sold as ENO · BIBAG · CARBEX · BICART · MOVICOL
- Drug class
- Salt Solutions
- Availability
- Prescription and OTC
- Routes
- Intravenous, Oral, Haemodialysis, Hemodialysis
- Markets covered
- 3
- Products on record
- 72
- FDA reports (12 mo)
- 1,810
Overview
Plain-language summary, compiled from the cited regulatory records
Sodium Bicarbonate is a medication classified as a salt solution [1]. It is indicated for the treatment of metabolic acidosis, which can arise in various conditions such as severe kidney disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal blood circulation, cardiac arrest, and severe primary lactic acidosis [1]. Additionally, it is used in managing certain drug intoxications, including those involving barbiturates when the dissociation of the barbiturate-protein complex is desired [1].
This active ingredient is available under several brand names, including QUABIC-100 and Sal de Uvas Picot [1]. In the past 12 months, there have been 1810 adverse event reports associated with Sodium Bicarbonate [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 39 | May 29, 2026 |
| CA Canada | Health Canada | 21 | May 21, 2026 |
| US United States | FDA | 12 | May 1, 2026 |
GBUnited Kingdom· MHRA
39 products
Uses
Sodium bicarbonate is indicated in adults (including elderly) for: • the treatment of metabolic acidosis arising from a variety of disorders. The dosage must be calculated on an individual basis and is dependent on the acid-base balance and electrolyte status of the patient.
• the short-term symptomatic treatment of mild or transient dyspepsia.
How to take
CACanada· Health Canada
21 products
Uses
9 PART III: CONSUMER INFORMATION ...................................... 12 JAMP-ElectroPEG Prescribing Information Page 3 of 14 JAMP-ElectroPEG Polyethylene Glycol 3350 and Electrolytes for Oral Solution, USP PART I: HEALTH PROFESSIONAL INFORMATION SUMMARY PRODUCT INFORMATION Route of Administration Dosage Form / Strength Clinically Relevant Non-medicinal Ingredients Powder for oral solution.
97 g For a complete listing see Dosage Forms, Composition and Packaging sections. INDICATIONS AND CLINICAL USE Adults JAMP-ElectroPEG, a polyethylene glycol (PEG)/electrolytes-based product, is indicated for: • Bowel cleansing prior to colonoscopy or barium enema x-ray examination or surgical procedures requiring a clean colon.
CONTRAINDICATIONS JAMP-ElectroPEG is contraindicated in patients with: • Ileus • Gastric retention • Bowel perforation • Gastrointestinal obstruction • Toxic colitis • Toxic megacolon • Hypersensitivity to this drug or to any ingredient in the formulation or component of the container.
USUnited States· FDA
12 products
Uses
Uses relieves: acid indigestion heartburn sour stomach upset stomach associated with these symptoms
How to take
Drug interactions
Known interactions involving Sodium Bicarbonate. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 334. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL556120023 · revised May 29, 2026
- [2]Health Canada (DPD) · 02406780 · revised August 21, 2025
- [3]FDA DailyMed · 0f867f56-4bc0-4a… · revised May 1, 2026 [PDF]
- [4]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.